Skip to content
  • Home
  • About Us
    • Our Team
      • Clinical Team
      • Research Team
    • Our Facilities
    • Contact Us
  • COPD Research Registry
  • Patient Information
    • Current Research Studies
      • ALA Lung Health Cohort
      • myAirvo 3 (High Flow Nasal Therapy; HFNT)
      • Oberon (Tozorakimab)
      • Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) 
    • More About COPD
  • Physician Resources
    • Current Clinical Trials
      • ALA Lung Health Cohort (Physician)
      • High Flow Nasal Therapy (Physician)
      • OBERON (Physician)
      • Roflumilast or Azithromycin to prevent COPD exacerbations (Physician)
  • Endobronchial Valve Program
Menu
  • Home
  • About Us
    • Our Team
      • Clinical Team
      • Research Team
    • Our Facilities
    • Contact Us
  • COPD Research Registry
  • Patient Information
    • Current Research Studies
      • ALA Lung Health Cohort
      • myAirvo 3 (High Flow Nasal Therapy; HFNT)
      • Oberon (Tozorakimab)
      • Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) 
    • More About COPD
  • Physician Resources
    • Current Clinical Trials
      • ALA Lung Health Cohort (Physician)
      • High Flow Nasal Therapy (Physician)
      • OBERON (Physician)
      • Roflumilast or Azithromycin to prevent COPD exacerbations (Physician)
  • Endobronchial Valve Program

Designation: Associate Director

Dr. Jessica Bon Field, MD, MS

© 2025 Emphysema COPD Research Center